ALB and nephrotic syndrome: A month after the beginning of treatment, the patient stopped taking the medication of his own accord and, when re-evaluated, he presented with recurrence of the nephrotic syndrome (uACR 3,800 mg/g, decrease of serum albumin from 3.5 to 2.2 mg/d, and fluid overload).